BenevolentAI Investor Conference Presentation Deck slide image

BenevolentAI Investor Conference Presentation Deck

DEMO Target Triage Triage criteria Biological Rationale 1 Ligandability 1 Safety 1 Tissue Expression Therapeutic Evidence ✰ Programs ALS demo Oxidative stress in ALS / ALS demo Filter Triage status Triaged (0) Assessment decision Match (5) Uncertain (5) Context Mechanism On other lists Present 1 Ligandability Not traged (12) Triage criteria Biological Rationale Safety Not match (2) Abs it Clear all Tissue Expression Therapeutic Evidence Tractability-class 4 (out of 4) Match GRM5 glutamate metabotropic receptor 5 Your comment (can be edited when changing target decision) Biological Rationale-class 3 (out of 4) Tractability-class 3 (out of 4) SLC7A11 solute carrier family 7 member 11 Biological Rationale-class 3 (out of 4) Uncertain Your comment (can be edited when changing target decision) Tractability-class 2 (out of 4) Uncertain Match NFE2L2 Biological Rationale-class 4 (out of 4) Tractability-class 4 (out of 4) Ligandability-cless 4 (out of 4) TRPV1 5 Target Rank? NFE2 like bZIP transcription factor 2 6 Ligandability-class 1 (out of 41 Biological Rationale-class 1 (out of 4) Safety-class 3 (out of 4) Your comment (can be edited when changing target decision) Target Rank? Ligandability-class 1 (out of 4) Safety-class 3 (out of 4) 7 Target Rank Your comment (can be edited when changing target decision) Safety-class 1 (out of 4) transient receptor potential cation channel subfamily V member 1 8 Ligandability-class 4 (out of 4) Safety-class 3 (out of 4) Tissue Expression-class 1 (out of 4) Tissue Expression-class 1 (out of 4) Tissue Expression-class 1 (out of 4) Target Rank? Tissue Expression-class 1 (out of 4) Therapeutic Evidence-class 1 (out of 3) Therapeutic Evidence-class 1 (out of 3) Therapeutic Evidence-class 1 (out of 3) Therapeutic Evidence-class 3 (out of 3) Benevolent 12
View entire presentation